|
|
|
26.06.25 - 00:21
|
Rakovina Therapeutics Announces Results from 2025 Annual General Meeting (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased to announce the results of voting at its 2025 annual general meeting of shareholders held on June 25, 2025, in Vancouver, British Columbia (the “Meeting”)....
|
|
|
23.06.25 - 20:06
|
XFRA: Deletion of Instruments from Boerse Frankfurt - 23.06.2025 (XETRA)
|
|
|
The following instruments on Boerse Frankfurt do have their last trading day on 23.06.2025
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.06.2025
ISIN Name
CA39261L2049 GREEN BATTERY MINERALS
CA75103L1013 RAKOVINA THERAPEUTICS
KYG3472Y1017 FIH MOBILE LTD DL-,04
LU0054735278 UNIEM FERNOST A INH.A
LU0126314995 UNIVALUEFONDS: EUROPA A
LU0126315372 UNIVALUEFONDS: EUROPA A N
US15117F8077 CELLECTAR NEW22 DL-00001
US38000Q2012 CRESCENT BIOPHARMA O.N....
|
|
|
23.06.25 - 17:12
|
XFRA: ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA39261L2049 Green Battery Minerals Inc. 23.06.2025 CA3194101067 First Canadian Grahite Inc. 24.06.2025 Tausch 1:1
US15117F8077 Cellectar Biosciences Inc. 23.06.2025 US15117F8804 Cellectar Biosciences Inc. 24.06.2025 Tausch 30:1
CA75103L1013 Rakovina Therapeutics Inc. 23.06.2025 CA75103L3092 Rakovina Therapeutics Inc. 24.06.2025 Tausch 10:1
KYG3472Y1017 FIH Mobile Ltd. 23.06.2025 KYG3472Y1199 FIH Mobile Ltd. 24.06.2025 Tausch 10:1
US38000Q2012 Crescent Biopharma Inc. 23.06.2025 KYG2545C1042 24.06.2025 Tausch 1:1...
|
|
|
20.06.25 - 17:03
|
Rakovina Therapeutics Announces Share Consolidation Effective Date (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) (“Rakovina” or the “Company”) is pleased to announce that the effective date for the previously announced share consolidation (the “Consolidation”) will be June 24, 2025. As outlined in the Company's news release dated May 15, 2025, the Consolidation will be conducted on the basis of one (1) post-consolidation common share (“Post-Consolidation Share”) for every ten (10) pre-consolidation common shares (“Pre-Consolidation Share”)....
|
|
|
|
|
06.06.25 - 22:09
|
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the closing of its previously announced non-brokered private placement for gross proceeds of $4,905,150 - consisting of $3,555,150 of Units and $1,350,000 of Debenture Units (each as defined below)....
|
|
|
|
|
|
|
29.05.25 - 00:48
|
Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”) announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust Company dated May 29, 2023 (the “Indenture”), certain holders (each, a “Debentureholder”) of 12.0% unsecured convertible debentures of the Company (the “Debentures”) have elected to receive common shares of the Company (the “Common Shares”) in lieu of cash in partial satisfaction of an aggregate total of approximately C$87,240 interest payable to all holders of the Debentures on May 29, 2025 (the “Interest Payment Date”). Approximately $16,740 of the interest payable under the Debentures will be settled by the issuance of Common Shares with the remaining $70,500 to be settled in cash on or about the Interest Payment Date....
|
|
|
|
|
|
|
|
|
05.05.25 - 14:33
|
Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the appointment of Dr. David M. Kideckel, Ph.D., MBA, as Chief Financial Officer (CFO), subject to approval from the TSX Venture Exchange (“TSXV”)....
|
|
|
|
|
30.04.25 - 04:03
|
Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the appointments of Mr. Yevgeniy Meshcherekov and Dr. David Kideckel to the Company's board of directors (the “Board”), subject to receiving approval from the TSX Venture Exchange (“TSXV”). The Company also announces that Michael Liggett has retired from the Board. Subject to TSXV approval, Mr. Meshcherekov will replace Mr. Liggett as the chair of the audit committee of the Board....
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
